Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
Clinical trial NCT05272826 · RECRUITING
Trial details
- NCT number
- NCT05272826
- Sponsor
- Canadian Myeloma Research Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2028-03-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.